Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 9.

Dreger, Peter, Doehner, Hartmut, Ritgen, Matthias, Boettcher, Sebastian, Busch, Raymonde, Dietrich, Sascha ORCID: 0000-0002-0648-1832, Bunjes, Donald, Cohen, Sandra, Schubert, Joerg, Hegenbart, Ute, Beelen, Dietrich ORCID: 0000-0001-5050-220X, Zeis, Matthias, Stadler, Michael, Hasenkamp, Justin, Uharek, Lutz, Scheid, Christof, Humpe, Andreas, Zenz, Thorsten, Winkler, Dirk, Hallek, Michael, Kneba, Michael, Schmitz, Norbert and Stilgenbauer, Stephan (2010). Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial. Blood, 116 (14). S. 2438 - 2448. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Kraemer, Isabelle, Stilgenbauer, Stephan, Dietrich, Sascha, Boettcher, Sebastian, Zeis, Matthias, Stadler, Michael, Bittenbring, Jorg, Uharek, Lutz, Scheid, Christof, Hegenbart, Ute, Ho, Anthony, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Doehner, Hartmut and Dreger, Peter (2017). Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood, 130 (12). S. 1477 - 1483. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kramer, Isabelle, Stilgenbauer, Stephan, Dietrich, Sascha, Bottcher, Sebastian, Ritgen, Matthias, Bunjes, Donald, Zeis, Matthias, Stadler, Michael, Bittenbring, Joerg Thomas, Hegenbart, Ute, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Dohner, Hartmut and Dreger, Peter (2016). Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Mai, Elias Karl ORCID: 0000-0002-6226-1252, Hose, Dirk, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G. H., Gerecke, Christian, Lindemann, Hans Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan and Goldschmidt, Hartmut (2014). Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma - Subgroup Analysis from the GMMG-MM5 Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Merz, Maximilian, Salwender, Hans ORCID: 0000-0001-7803-0814, Haenel, Mathias, Mai, Elias K., Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S., Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan and Goldschmidt, Hartmut (2016). Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. Haematologica, 101 (12). S. E485 - 3. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Merz, Maximillan, Salwender, Hans-Juergen, Haenel, Mathias, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Mai, Elias Karl ORCID: 0000-0002-6226-1252, Hose, Dirk, Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans Walter, Zeis, Matthias, Weisel, Katja C., Duerig, Jan and Goldschmidt, Hartmut (2015). Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Scheffold, Annika, Jebaraj, Billy Michael Chelliah, Jaramillo, Sonia, Tausch, Eugen, Steinbrecher, Daniela, Hahn, Michael, Boettcher, Sebastian, Ritgen, Matthias, Bunjes, Donald, Zeis, Matthias, Stadler, Michael, Uharek, Lutz, Scheid, Christoph, Hegenbart, Ute, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Doehner, Hartmut, Dreger, Peter and Stilgenbauer, Stephan (2017). Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial. Br. J. Haematol., 179 (2). S. 342 - 347. HOBOKEN: WILEY. ISSN 1365-2141

Scheffold, Annika, Jebaraj, Billy Michael Chelliah, Tausch, Eugen, Boettcher, Sebastian, Ritgen, Matthias, Bunjes, Donald, Zeis, Matthias, Stadler, Michael, Uharek, Lutz, Scheid, Christof, Hegenbart, Ute, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Doehner, Hartmut, Dreger, Peter and Stilgenbauer, Stephan (2014). Telomere Lenght and Outcome of Allogeneic Stem Cell Transplantation for Poor Risk Chronic Lymphocytic Leukemia: Results from the GCLLSG CLL3X Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Scheid, Christof, Hielscher, Thomas, Bertsch, Uta, Kunz, Christina, Salwender, Hans, Haenel, Mathias, Merz, Maximilian, Mai, Elias Karl ORCID: 0000-0002-6226-1252, Hose, Dirk, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo, Gerecke, Christian, Lindemann, Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Jauch, Anna and Goldschmidt, Hartmut (2014). Influence of Renal Impairment and Genetic Risk Factors on Response to Induction Therapy in the HD4 and MM5 Trials of the GMMG. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Thu Mar 28 22:24:26 2024 CET.